One sentence summary: Comparative genomic and transcriptomic analyses unveil a new gain-of-function mutation in CgPdr1 transcription factor, a key player mediating drug resistance in Candida glabrata. Editor: Carol Munro
INTRODUCTION
An alarming increase in the incidence of infections caused by Candida glabrata has been reported in the last years (Fidel, Vazquez and Sobel 1999; Khatib et al. 2016) . As such, in most epidemiological surveys this species ranks as the second major causative agent of invasive fungal infections worldwide, behind C. albicans and in some cases it is even the most frequently isolated species (Fidel, Vazquez and Sobel 1999; Pfaller et al. 2010 ). This increase in the incidence of infections caused by C. glabrata is believed to result from its naturally high resilience to azoles, the frontline antifungal therapy used to treat candidiasis (Fidel, Vazquez and Sobel 1999; Pfaller et al. 2010) . The remarkably high rate at which C. glabrata strains acquire resistance to azoles, higher than the one registered for any other Candida spp., is another key factor contributing for the emergence of resistant strains (Borst et al. 2005; Pfaller et al. 2013; Kolaczkowska and Kolaczkowski 2016) . Mutations in Erg11, the enzyme targeted by azoles, is not a primary mechanism of resistance in C. glabrata, in contrast with what is observed to occur for other Candida species (Sanguinetti et al. 2005; Tsai et al. 2010; Kolaczkowska and Kolaczkowski 2016) . This observation suggests that C. glabrata has evolved other mechanisms to cope with azole stress, in particular through the activity of multidrug resistance (MDR) transporters (Sanguinetti et al. 2005; Kolaczkowska and Kolaczkowski 2016) . Specifically, several reports have underlined the important role of the ABC drugefflux pumps CgCDR1 and CgPDH1 in contributing to azole resistance both in both laboratory strains and in resistant clinical isolates (Sanglard et al. 1999; Vermitsky and Edlind 2004; Sanguinetti et al. 2005; Torelli et al. 2008; Kolaczkowska and Kolaczkowski 2016) . More recently, the involvement of MDR transporters belonging to the major facilitator superfamily in azole resistance of C. glabrata has also been described (Costa et al. 2014) .
The transcriptional regulation of drug-efflux pumps in C. glabrata, as in other yeasts, relies on the activity of the wellorganised regulatory pleiotropic-drug resistance (PDR) network (Kolaczkowska and Kolaczkowski 2016) . In C. glabrata, the key regulator of the PDR network is the transcription factor CgPdr1 and, concomitantly, this has been demonstrated to play an essential role in conferring tolerance to azoles (Vermitsky and Edlind 2004; Vermitsky et al. 2006) , including in resistant clinical isolates (Sanglard et al. 1999; Sanguinetti et al. 2005; Tsai et al. 2006 Tsai et al. , 2010 Ferrari et al. 2009; Caudle et al. 2011) . CgPdr1 has been implicated in the regulation of the drug-efflux pumps CgCDR1, CgPDH1, CgQDR2 and CgYOR1 (Kolaczkowska and Kolaczkowski 2016) . Other azole-responsive genes regulated by CgPdr1 have biological functions related to stress response, metabolism of fatty acids and sterols, transcriptional regulation and adhesion (Vermitsky et al. 2006; Ferrari et al. 2009 Ferrari et al. , 2011 Tsai et al. 2010; Caudle et al. 2011) . Analysis of the coding sequence of the CgPDR1 gene in susceptible and resistant clinical isolates identified a panoply of gain-of-function (GOF) mutations that are believed to constitutively activate the transcription factor resulting in enhanced C. glabrata azole resistance (Vermitsky and Edlind 2004; Vermitsky et al. 2006; Torelli et al. 2008; Ferrari et al. 2009; Caudle et al. 2011) .
In this work, the genome and transcriptome of the reference strain C. glabrata CBS138 and of a clinical isolate (named FFUL887) recovered along the course of an epidemiological survey undertaken in hospitals of the Lisbon area herein demonstrated to be resistant to voriconazole and fluconazole (while the CBS138 strain was found to be sensitive) were compared. Besides providing clues to the mechanisms underlying acquisition of azole resistance inside the host, the results may also contribute for a better understanding of the different responses evolved by C. glabrata in human colonisation.
METHODS

Strains and growth media
The strains used in this work are listed in Table 1 . In addition to the laboratory strains listed, a cohort of 58 Candida glabrata clinical isolates recovered from patients attending three major Hospitals of the Lisbon area between 2000 and 2008 was also used (Table S1 , Supporting Information). The strains were cultivated in rich growth media Yeast Peptone Dextrose (YPD), in RPMI (Roswell Park Memorial Institute Medium) or in minimal medium (MM). YPD contains, per litre, 20 g glucose (Merck Millipore), 10 g yeast extract (HiMedia Laboratories, Mumbai, India) and 20 g Peptone (HiMedia Laboratories). RPMI contains, per litre, 20.8 g RPMI-1640 synthetic medium (Sigma), 36 g glucose (Merck Millipore), 0.3g of L-glutamine (Sigma) and 0.165 mol/L of MOPS (3-(N-morpholino) propanesulfonic acid, Sigma). MM contains, per litre, 20 g glucose (Merck Millipore), 2.65 g (NH 4 ) 2 SO 4 (Merck Millipore) and 1.7 g of yeast nitrogen base without amino acids and without ammonium sulphate (Difco). YPD and MM medium were sterilised by autoclaving for 15 min at 121
• C and 1 atm, while RPMI medium was filtered with a 0.22-μm pore size filter and preserved at 4 • C until further use. Solid media was prepared supplementing the corresponding liquid media with 2% agar.
Assessment of resistance to antifungals
To assess the resistance of the C. glabrata clinical isolates and of the reference strain CBS138 to voriconazole, fluconazole, anidulafungin and caspofungin, the MIC 50 (minimum inhibitory concentration) of each of the antifungals was estimated using the microdilution method recommended by EUCAST (Subcommittee on Antifungal Susceptibility is not yet established for voriconazole in C. glabrata, the epidemiological cut-off value (1 mg/L) was used to detect non-WT isolates as recommended (Pfaller et al. 2011) . The stock solutions of the antifungals were prepared from the powder and using DMSO (dimethyl sulfoxide, Sigma) as the solvent. Fluconazole was purchased from Sigma, voriconazole and anidulafungin were kindly provided by Pfizer and caspofungin was provided by Merck Sharp Dohme. Growth curves of the C. glabrata reference strain CBS138 and of the FFUL887 isolate in the presence of fluconazole and voriconazole were performed using essentially the same experimental setup described above for the microdilution method with the difference that instead of measuring OD of the culture only after 24 h, this was measured every 30 min during 42 h at OD 590nm .
FFUL887 genomic DNA extraction and whole-genome sequencing
FFUL887 cells were cultivated in YPD growth medium (up to an OD 600nm of ∼3.0) and then centrifuged at 5000 rpm for 5 min at 4 • C. The pellet was resuspended in 1 ml solution A (1 M Sorbitol (Sigma); 0.1 M EDTA (tetrasodium salt dehydrate) at pH 7.5). Afterwards, 10 mg/mL zymolyase (Zymo research) was added to the cellular suspension and the solution was incubated at 37˚C until protoplast formation. The suspension was centrifuged at 5000 rpm for 5 min and the pellet was resuspended in 1 mL solution B (50 mM Tris-HCL at pH 7.4 (Sigma-Aldrich), 20 mM EDTA). After this step, 30 μL of SDS (10%) was added to the mixture and this was left for 30 min at 65 • C. Potassium acetate (250 μL, 5 M; Merck) was subsequently added and the mixture was left for 1 h on ice. The suspension was clarified by centrifugation (10 000 rpm, 10 min), and the supernatant was transferred to two fresh microfuge tubes. One volume of cold isopropanol was used to precipitate the pellet followed by centrifugation at 5000 rpm for 15 min. Supernatant was discarded, and the resulting pellet was incubated in 1 mL ethanol 70% during 5 min, and washed with ethanol 70% twice. The pellet was then dried in speed vacuum and resuspended in 200 μL TE (pH 7.4). 0.5 μL of RNase (10 mg/ml) was added followed by 1-h incubation at 37
Mixture was centrifuged at 10 000 rpm for 15 min, and the supernatant was preserved at 4
• C till further use. FFUL887 genome sequencing was based on Ion Torrent and was performed by Stab Vida (Portugal) as a paid service. Two rounds of paired-end sequencing were performed which resulted in ∼6 million reads with an average size of 199 bp. The reads were trimmed based on quality and for SNP calling the trimmed reads were mapped against the reference genome of CBS138 (available on Candida Genome Database) using CLC Genomics Workbench. To increase confidence on the results obtained variant detection was performed from the mapped reads using both the probabilistic and quality-based variant detection tools embedded on CLC. To annotate the genome of the FFUL887 strain, the reads were de novo assembled into 799 contigs yielding a total of assembled 
CgPDR1 gene disruption
The deletion of the C. glabrata PDR1 (CAGL0A00451g) in strain KUE100 (parental to the CgPDR1 mutant used in spot assays) was carried out using the method described by Ueno et al. (2011) . The target gene CgPDR1 was replaced by a DNA cassette including the CgHIS3 gene through homologous recombination. The replacement cassette was prepared by PCR (Table 2) . Recombination locus and gene deletion were verified by PCR. Deletion of the same gene in the background of the clinical isolate strain FFUL887 was carried out using a little modified method from the one above described for the KUE100 strain. In specific, Cg-PDR1 was replaced by a DNA cassette containing the zeocinresistant marker by homologous recombination. Transformants were isolated on YPD supplemented with 100 μg/ml zeocin. Correct insertion of the zeocine resistance cassette and corresponding deletion of CgPDR1 were verified by PCR and by confirming the absence of CgPDR1 expression in the mutant strains by realtime RT-PCR (primers available in Table 2 ).
Transcriptomic analysis
The transcriptomes of FFUL887 and CBS138 strains were compared using DNA microarrays specifically designed for C. glabrata (design ID 064590) (Rossignol et al. 2007) . Both strains were cultivated overnight in 25 mL of YPD at 30
• C with orbital agitation (250 rpm) and then re-inoculated (at an OD 600nm of 0.2 ± 0.05) in 150 mL of fresh RPMI. The cells were harvested by centrifugation (8000 × g, 7 min, 4
• C-Beckman J2.21 Centrifuge, rotor JA.10)
in mid-exponential phase (OD 600nm ∼2 ± 0.05) and immediately frozen at -80 • C until further use. RNA extraction was performed as described in Bernardo et al. (2017) and in Rossignol et al. (2007) .
Comparison of gene transcript levels based on real time RT-PCR
The expression of CgCDR1, CgPDH1, CgQDR2 and CgPDR1 genes was compared in CBS138, in FFUL887 and in FFUL Cgpdr1 strains by real-time RT-PCR. Cells of the different strains were cultivated in identical conditions to those used for the microarray analysis. Conversion of total RNA into cDNA was performed using 1 μg of RNA. The reverse-transcription step was performed in a C1000 Thermal Cycler (Bio-Rad, Hercules, USA). The subsequent quantitative PCR step was performed using 2.5 μL of the cDNA. The sequence of the primers used is available on request. Gene expression was calculated using CgRDN5.8 as an internal control.
Comparison of susceptibility to environmental stressors based on spot assays
Comparison of susceptibility of CBS138, KUE100, KUE100 CgPDR1, FFUL887 and FFUL887 CgPDR1 cells to inhibitory concentrations of H 2 O 2 and of the organic acids acetic, propionic and butyric acids was based on spot assays. Cells of the different strains were cultivated in MM growth medium until mid-exponential phase (OD 600nm ∼0.8) and then diluted in 1 mL of sterile water to obtain a cell suspension having an OD 600nm of 0.05. Four microlitres of this cell suspension and of two subsequent dilutions (1:5 and 1:10) were applied onto the surface of MM agarised plates supplemented or not with inhibitory concentrations of H 2 O 2 (5-18 mM), of acetic acid (50-60 mM), of propionic acid (17-20 mM) and of butyric acids (15-17 mM). The plates were incubated at 30
• C for 2 to 3 days depending on the severity of growth inhibition. The same experimental setup was used to assess susceptibility of the strains to heat stress with the difference that instead of incubating the inoculated plates at 30
• C, these were incubated at 37
RESULTS
Identification of FFUL887 as a fluconazole-and voriconazole-resistant strain
To characterise the incidence of resistance to fluconazole, voriconazole, caspofungin and anidulafungin in a cohort of 58 Candida glabrata clinical isolates, the concentration of each of these antifungals leading to a 50% growth inhibition (generally designated as MIC 50 ), comparing with growth registered in drugfree medium, was determined. This phenotypic screening was performed using the highly standardised microdilution method recommended by EUCAST. As a control we have also included the reference strain CBS138 in the screening. The MIC value obtained for each drug and each isolate is shown in Fig. S1 (Supporting Information), and the distribution of MIC values across all isolates is shown in Fig. 1 (Fig. S1) . Notably, three of the crossresistant isolates (FFUL412, FFUL443 and FFUL674) were retrieved from patients undergoing fluconazole-based therapy (Table S1). Despite the small number of isolates examined in this study, the percentage of resistance obtained for fluconazole and voriconazole (16% for fluconazole and 14% for voriconazole) are close to the values reported (10%-15%) in antifungal surveillance tests undertaken with much larger cohorts of strains (e.g. Pfaller et al. 2010) . None of the C. glabrata isolates tested could be considered susceptible to fluconazole as the MIC values were always above 0.002 mg/L (Fig. S1 ), consistent with the described increased resilience of C. glabrata to this azole drug (Fidel, Vazquez and Sobel 1999; Kolaczkowska and Kolaczkowski 2016 ). All the isolates tested exhibited high susceptibility to anidulafungin, none of them exhibiting growth when cultivated in the presence of 0.06 mg/L, the defined resistance breakpoint ( Fig. 1B; Fig.  S1 ). For caspofungin, only one isolate, FFUL887, exhibited a MIC value of 0.25, while for the remaining isolates this MIC value was of 0.125 or below ( Fig. 1B; Fig. S1 ). The FFUL887 strain was selected for further analysis since it was demonstrated to be resistant to fluconazole and voriconazole and also exhibited higher resilience to caspofungin compared to the other clinical isolates in this study. To assess how the presence of the fluconazole and voriconazole affected growth kinetics of the FFUL887 and CBS138 strains, growth curves in liquid medium were performed using the same experimental setup that was used for estimation of MIC 50 (Fig. S2, Supporting Information) . Three concentrations of voriconazole and fluconazole were tested: one corresponding to the resistance breakpoint, one below and one above that value (Fig.  S2) . The results obtained show that the two strains exhibited a similar fitness when cultivated in drug-free medium, with only a slight decrease in the final biomass produced by the FFUL887 strain (Fig. S2) . Supplementation of the RPMI medium with the two azole drugs led to a drastic growth inhibition of the CBS138 strain, whereas growth of the FFUL887 strain was almost identical to the control conditions, with only a small detectable decrease of the growth rate (e.g. 0.033 h −1 in the presence of 64 mg/L fluconazole and 0.044 h −1 in control conditions) (Fig. S2) and a slight increase in the lag phase that was observed upon inoculation in the drug-supplemented medium (Fig. S2 ).
To assess if the resistant phenotype exhibited by the FFUL887 strain towards fluconazole and voriconazole was generalised for azoles or was limited to azoles of the triazole family (including fluconazole or voriconazole), growth of this strain in the presence of the imidazoles ketoconazole and clotrimazole was examined ( Fig. S3 , Supporting Information). Cells were cultivated for 24 h in 96-multiwell plates containing RPMI or in the same growth medium supplemented with 4 mg/L ketoconazole and 1 mg/mL of clotrimazole, the defined resistance breakpoints for these two drugs. Figure S3 shows that FFUL887 cells are more tolerant to the tested concentrations of ketoconazole and clotrimazole than the CBS138 strain; however, the FFUL887 strain is still considered susceptible to the two imidazoles since the concentrations tested reduced growth by more than 50% the one registered in control conditions (Fig. S3) .
FFUL887 genome sequencing and annotation
The fluconazole and voriconazole resistance phenotype exhibited by the FFUL887 strain prompted us to obtain the genome sequence of this isolate. The assembled contig sequences were used for automatic ab initio gene detection that was subsequently manually curated to select the more appropriate gene models. This analysis allowed us to predict that the ORFeome of the FFUL887 strain includes 5079 genes, which corresponds to 96% of the total number of genes annotated for the CBS138 strain (Dujon et al. 2004) . The number of ORFs obtained for the FFUL887 is also in line with those recently reported for other C. glabrata clinical isolates (in the range of 5300 CDSs) (Havelsrud and Gaustad 2017; Vale-Silva et al. 2017) . The vast majority (5039) of the protein pairs present in CBS138 and FFUL887 shared more than 90% identity at the amino acid level indicating that the proteins encoded by the two strains are fairly similar. For the identification of SNPs that could underlie the observed resistance to fluconazole and voriconazole of the FFUL887 strain, the reads obtained were mapped against the genome sequence of the CBS138 strain, as detailed in materials and methods section. This comparison yielded 77 749 SNPs between the genomes of FFUL887 and CBS138 (Fig. S4, Supporting Information) . A similar high number of SNPs was also reported in a recent comparative genomic analysis between two C. glabrata clinical isolates and the reference strain CBS138 (Vale-Silva et al. 2017) . About 45% of the SNPs identified between CBS138 and FFUL887 were located in coding regions, affecting 3194 of the gene sequences predicted for the FFUL887 strain (Fig. S4) . The percentage of genes harbouring non-synonymous SNPs in the FFUL887 strain was similar throughout the nine C. glabrata nuclear chromosomes (∼60%) but considerably smaller (∼18%) in the mitochondrial chromosome (Fig. S4) . On average, FFUL887 and CBS138 orthologous genes harboured five non-synonymous SNPs; however, in some cases this number increased up to more than 30 non-synonymous SNPs including in CAGL0K12078g (>50 non-synonymous SNPs), encoding a putative transcription factor similar to ScNrg1 transcription factor; CAGL0C00231g (42 non-synonymous SNPs), encoding a presumed plasma membrane nucleobase transporter, and the adhesin CgPWP4 (52 nonsynonymous SNPs) (Fig. 2) . Other adhesin-encoding genes were also observed to harbour a high number of non-synonymous SNPs between FFUL887 and CBS138 including CgEPA8, CgPWP5, CAGL0C03575g and CAGL0L10092g (Fig. 2) .
Notably, no SNPs were found in the sequence of ERG11 gene encoded by FFUL887, consistent with the idea that azole resistance of these strains is not driven by alterations in the drug target as shown for most C. glabrata azole-resistant isolates (Sanguinetti et al. 2005; Tsai et al. 2010; Kolaczkowska and Kolaczkowski 2016) . No SNPs were also found in FFUL887 Msh2, a DNA repair protein whose mutations had been linked to the development of azole resistance in C. glabrata-resistant clinical strains (Healey et al. 2016) . Concerning the CgFKS1 and CgFKS2, the two enzymes targeted by echinocandins, the FFUL887 alleles harbour one non-synonymous SNP each (Gly14Ser in CgFks1 and Figure 2 . Number of non-synonymous SNPs present in FFUL887 predicted proteins, when compared with their CBS138 counterpartners. The reads obtained after whole-genome sequencing of the FFUL887 strain were mapped against the genome of the reference strain CBS138, as detailed in materials and methods section. Those genes exhibiting a higher number of non-synonymous SNPs in the FFUL887 strain are highlighted in the figure. Adhesin-encoding genes are evidenced in light blue. Table 3 . Subset of proteins previously described to be involved in fluconazole and/or voriconazole resistance in C. glabrata and that were found to harbour non-synonymous SNPs in the FFUL887 strain, when compared with their CBS138 counterpartners.
Gene or ORF name
Function Amino acid modification found in FFUL887
CgPDR1
Zinc finger transcription factor, activator of drug resistance genes Val91Ile; Leu98Ser; Asp243Asn; Lys274Gln CgGAL11A CgGAL11B
Component of the transcriptional Mediator complex that provides interfaces between RNA polymerase II and upstream activator proteins; essential for CgPdr1-dependent activation of azole-resistance genes Ser134Asn; Ser965Gly; Ser1084Asn Gln203Pro; His322Asn; Pro372Ser; Ile615Asn; * 839Gly
CgPDH1
Multidrug transporter of the ATP-binding cassette superfamily Lys438Gln; Glu839Asp CAGL0L04400g
Zinc finger transcription factor involved in transcriptional regulation of MDR genes. Orthologue of S. cerevisiae ScYRR1
Cys24Gly; Ala58Val; Ile137Leu; Asp229Glu; Ile346Val; Glu574Lys; Ile593Leu; Glu710Asp; Ala933Val CgUPC2A
Zinc finger transcription factor required for transcriptional regulation of genes involved in uptake and biosynthesis of ergosterol Arg92Lys; Asn304Ser; Glu822Val
CgSIN3
Component of the Rpd3S and Rpd3L histone deacetylase complexes
Asn50Lys; Lys288Thr
CAGL0L03377g
Predicted zinc finger transcription factor; required for resistance to voriconazole and fluconazole Gly134Asp; Gly172Ser; Lys252Arg; Ile347Met; Ala695Gly; Lys813Arg; Asp819Glu; Thr867Met CAGL0L09383g
Predicted zinc finger transcription factor; required for resistance to voriconazole and fluconazole Ser116Asn; Ile185Val; Met202Val
CgHST1
Histone deacetylase that regulates gene expression in niacin-limiting conditions
Met70Lys
Thr926Pro in CgFks2), compared to CBS138 orthologues; however, these polymorphisms are outside of the hotspot regions commonly found to be altered in echinocandin-resistant isolates (Garcia-Effron et al. 2009 ). It thus remains to be examined whether the higher tolerance of the FFUL887 strain to caspofungin comes from these polymorphisms or if it results from other genetic traits.
Comparative genomic analysis between FFUL887 and CBS138 focused on azole-resistance genes: emphasis on CgPdr1
To gather insights into the differential levels of resistance to fluconazole and voriconazole of the CBS138 and FFUL887 strains, the set of proteins found to harbour non-synonymous SNPs in the resistant strain were compared with a comprehensive list of 78 genes previously implicated in C. glabrata resistance to fluconazole and voriconazole (listed in Table S2 , Supporting Information). Fifty-three genes associated with resistance to these two azoles differed in FFUL887 and in CBS138, a subset of these being shown in Table 3 . One of the proteins that differed between FFUL887 and CBS138 is CgPdr1, which exhibited four non-synonymous SNPs (Val91Ile, Leu98Ser, Asp243Asn and Lys274Gln), when compared with the corresponding CBS138 orthologue. Three of these SNPs (Val91Ile; Leu98Ser and Asp243Asn) were found to be present simultaneously in the CgPDR1 alleles encoded by isolates resistant and susceptible to azoles (Ferrari et al. 2009 ), while the Lys274Gln was not previously described. Based on this observation, it was hypothesised that the substitution K274Q could represent a GOF substitution of C. glabrata CgPdr1. To test the hypothesis that K274Q mutation leads to hyperactivation of CgPdr1, the transcriptomes of the FFUL887 and CBS138 strains were compared in drug-free RPMI medium using species-specific DNA microarrays. Out of the 409 genes found to be overexpressed in the FFUL887 strain (above 1.5-fold, P-value below 0.001; listed in Table S3 , Supporting Information), 89 genes are documented targets of CgPdr1, according to the information * * * * P-value below 0.0001; (B) comparison of the transcript levels of CgPDR1, CgCDR1, CgPDH1 and CgQDR2 genes in CBS138, FFUL887 and the FFUL887 CgPDR1 strains. Cells of the different strains were cultivated in RPMI growth medium until mid-exponential phase after which the expression of CgPDR1, CgCDR1, CgPDH1 and CgQDR2 genes was compared by qRT-PCR. The values represented for the FFUL887 and FFUL887 CgPDR1 strains are relative to the value obtained for the CBS138 strain, which was considered to be equal to 1. For the statistical analysis, the results obtained for the FFUL887 strain were compared with those gathered for CBS138, while the results obtained for the FFUL887 CgPDR1 mutant were compared with those obtained for FFUL887. * P-value below 0.05, * * * * P-value below 0.0001.
available in the PathoYeastract database (Monteiro et al. 2017) (highlighted in grey in the Table S3 ). Among these were the well-characterised CgPdr1 targets CgPDH1 and CgCDR1, as well as CgPDR1 itself (Table S3) . Deletion of CgPDR1 K274Q abrogated the increase in transcription of CgPDH1, CgCDR1, CgPDR1 and CgQDR2 genes registered in the FFUL887 strain (Fig. 3A) . As expected, deletion of the CgPDR1 K274Q allele also resulted in sensitisation of the FFUL887 strain to fluconazole and voriconazole (Fig. 3B) . Overall, the results of the transcriptomic profiling of the CBS138 and FFUL887 strains strongly support the idea that FFUL887 encodes a CgPdr1 GOF allele, resulting from the K274Q SNP.
The deletion of CgPDR1 K274Q allele affects tolerance to environmental stress of the FFUL887 isolate
Previous studies have shown that deletion of GOF CgPdr1 alleles results in altered stress resilience of azole-resistant C. glabrata strains (Vermitsky et al. 2006) . We therefore compared growth of CBS138, FFUL887 and FFUL887 CgPDR1 K274Q in the presence of various environmental stressors including H 2 O 2 , acetic acid, propionic acid, butyric acid and at different temperatures (30
Under the experimental conditions used, the deletion of CgPDR1 in the FFUL887 background led to a mild decrease in growth of the strains when cultivated at all the temperatures tested (Fig. 4) . No significant differences were observed upon CgPDR1 deletion in the FFUL887 background concerning tolerance to H 2 O 2 but, surprisingly, during cultivation in the presence of inhibitory concentrations of the organic acids acetic, propionic and butyric acids (at pH 4.5) the deletion of CgPDR1 K274Q was beneficial (Fig. 4) . These experiments were also performed in the genetic background of the laboratory strain KUE100 that encodes a wild-type CgPdr1 allele. The results obtained confirmed a slight protective effect exerted by CgPDR1 expression against high temperatures, while in the presence of acetic, propionic or butyric acids there was no significant differences in growth of the wild-type or of the CgPDR1 mutant (Fig. 4) .
Comparative transcriptomic analysis between FFUL887 and CBS138 shows dramatic alterations in the expression of genes involved in carbohydrate, nitrogen and sulphur metabolism
We have further explored our results concerning the comparison of the transcriptome of the FFUL887 and CBS138 strains during growth in RPMI medium aiming to gain insights into the responses evolved by C. glabrata during colonisation of the human urinary tract considering that this was the niche where FFUL887 isolate was retrieved from. The CBS138 strain has an intestinal origin; however, its extensive utilisation in the laboratory as likely resulted in its domestication leading to large phenotypic differences compared to those observed in C. glabrata clinical isolates including those of intestinal origin (Gregori et al. 2007; Cunha et al. 2017) . The genes overexpressed (above 1.5-fold and having a P-value below 0.001) in the FFUL887 isolate were clustered according to their biological function using the MIPS functional catalogue (Fig. S5, Supporting Information) . Results revealed a significant enrichment (P-value below 0.001) of genes involved in 'metabolism of amino acids', 'metabolism of carbohydrates', 'nitrogen, sulphur and selenium metabolism', 'lipid, fatty acid and isoprenoid metabolism', 'generation of energy', 'vacuolar protein degradation', 'transport' and 'oxidative stress response' (Fig. S5 and Table S3 ). Similarly, the set of genes upregulated in CBS138 (and consequently downregulated in FFUL887) was enriched (P-value below 0.001) in genes related with 'protein synthesis' (Fig. S5 and Table S3 ).
The genes upregulated in the FFUL887 strain related with carbohydrate and lipid metabolism included enzymes involved in fatty-acid β-oxidation, in catabolism of acetate, of propionate and of glycogen, as well as genes encoding neoglucogenic and Krebs cycle enzymes (Fig. S6 , Supporting Information). This observation was surprising considering that at the time point where FFUL887 and CBS138 cells were harvested for the microarray analysis (after 6 h of cultivation in the rich RPMI medium supplemented with 20 g/L glucose) there was still a considerable amount of glucose present in the culture supernatant of the two cultures (∼18.5 g/L, based on HPLC analysis of the Comparison of the susceptibility of CBS138, FFUL887 and the FFUL887 CgPDR1 strains to environmental stressors based on spot assays. Mid-exponential phase cells of the different strains were cultivated in solid MM growth medium or in this same medium supplemented with inhibitory concentrations of H2O2 or of the fatty acids acetic acid, propionic acid and butyric acid. Lanes b and c correspond to 1:5 and 1:10 dilutions of the cell suspension used in lane a. Growth was compared after 2 to 3 days of incubation at 30
• C, depending on the severity of growth inhibition. The same experimental setup was used to compare tolerance of the strains to different temperatures.
supernatants). The genes upregulated in the FFUL887 strain related with amino acid and sulphur metabolism classes were essentially those involved in metabolism of various amino acids and genes of the trans-sulfuration pathway that allows transport and incorporation of sulphate in methione and cystheine (Fig. S6) . Consistently, several transporters involved in the uptake of amino acids, small peptides and inorganic sulphur were also found to be upregulated in the FFUL887 strain (Fig. S6 ).
DISCUSSION
In this work, we have disclosed the genome sequence of a Candida glabrata clinical isolate, FFUL887, resistant to voriconazole and fluconazole and also exhibiting enhanced tolerance to caspofungin. The higher resistance of the FFUL887 strain to these two types of antifungals is striking considering that they have different modes of action. Resistance to voriconazole and fluconazole in FFUL887 was largely dependent on the expression of CgPdr1; however, this is not likely to underlie the higher tolerance of this strain to caspofungin since CgPdr1 expression is dispensable for C. glabrata tolerance to echinocandinds (Schwarzmuller et al. 2014) . A very high number of SNPs were obtained when comparing the genomic sequences of CBS138 and FFUL887, probably reflecting the different genetic background of these two strains. Nevertheless, the vast majority of the proteins encoded by the two strains were still very similar with >90% of the proteins encoded by the two strains sharing a degree of homology above 90%. Recent comparative genomic analysis between C. glabrata clinical isolates and the CBS138 strain also revealed very prominent differences, within the range of those reported in our study (Havelsrud and Gaustad 2017; Vale-Silva et al. 2017) , while a strain used for carboxylic acids production was much more similar to CBS138 (Xu et al. 2016) . Interestingly, even the comparison of cohorts of related clinical isolates shows very prominent differences, similar to those that are observed when the isolates are compared with the CBS138 strain (Vale-Silva et al. 2017) . These observations reflect the described genomic plasticity of C. glabrata species which gives rise to a large genetic and phenotypic diversity among isolated strains (Carreté et al. 2017) . While in our study we have focused on the comparison between the transcriptome and genome of an azole-resistant strain with the susceptible CBS138 strain, others have performed similar analyses but using related isolates (for example, strains retrieved from patients obtained before and after application of azole-therapy (Vermitsky and Edlind 2004; Vermitsky et al. 2006; Vale-Silva et al. 2017) ). In our case, a similar approach was not possible since we could not identify among the sensitive strains tested one that could be related with FFUL887. Necessarily, the option of comparing the genomes of CBS138 vs FFUL887 is difficult for the establishment of genotype-phenotype associations; however, it has the advantage of allowing the identification of new SNPs that could be relevant for azole resistance and that would not be detected when comparing two already adapted clinical strains such as modifications occurring early during the process of colonisation of the human host. Besides CgPdr1, several other well-characterised determinants of C. glabrata resistance to azoles were found to harbour SNPs in the resistant strain FFUL887 including the MDR transporters CgPhd1, CgTpo1 1 and CgTpo1 2 and the transcriptional regulators CgUpc2A, CgYrr1, CgStb5 and CgGal11A (Table S2 ). It is difficult to understand whether these polymorphisms contribute to the higher resistance exhibited by FFUL887 cells towards fluconazole and voriconazole because the biochemical activity of these proteins is not well studied, and therefore it is hard to predict the consequences for protein activity of the identified SNPs. Nevertheless, these indicatives deserve further exploration since azole-resistance genes are surely under selective pressure, as occurs with CgPdr1. Venn diagram comparing the set of genes regulated by the CgPdr1 GOF mutants K274Q, K274N, P927L and L946S, as revealed by transcriptomic analyses. The set of genes herein identified as being upregulated in the FFUL887 isolate and harbouring in their promoter region a PDRE motif (TCCRYGSR) was compared with the set of genes previously described to be under the regulation of K274N, P927L and L946S CgPdr1 GOF mutations (Vermitsky et al. 2006; Tsai et al. 2010 ).
The extensive upregulation of about 90 documented targets of CgPdr1 that was observed in the FFUL887 strain during cultivation in drug-free growth medium strongly supports the idea that the K274Q substitution is, indeed, a new GOF mutation of this protein. Interestingly, a K274N substitution has been previously reported, however, while this results in mild increase in fluconazole tolerance (MIC of 16 mg/L) (Caudle et al. 2011) , the herein reported K274Q substitution results in a much higher resistance (MIC of 64 mg/L). The K274 residue lies within a region of CgPdr1 where several other mutations have been described (as detailed in Fig. S7 , Supporting Information) and is located near a predicted inhibitory regulatory domain of CgPdr1 (residues 322-465) (Fig. S7) . In Saccharomyces cerevisiae, this regulatory domain inhibits the activity of ScPdr1 (Kolaczkowska et al. 2002) , for which it can be hypothesised that the K274Q modification could compromise the function of the inhibitory domain resulting in an hyperactivation of CgPdr1. Further studies are required to better understand how the K274Q and other GOF mutations modulate the activity of CgPdr1.
The genes that are under regulation of different CgPdr1 GOF mutants have a modest overlap (Ferrari et al. 2009 (Ferrari et al. , 2011 Tsai et al. 2010; Caudle et al. 2011) . In order to determine the effect of the CgPdr1 K274Q substitution in C. glabrata genomic expression, the 92 genes upregulated in the FFUL887 strain harbouring a PDRE motif (TCCRYGSR) in their promoter (presumed to be the direct targets of CgPdr1) were compared with the set of genes regulated by three other GOF alleles: P927L and L946S and K274N (Fig. 5) . Only five genes were in common in the three datasets: CgCDR1, CgYOR1, CgPDR1, CgPUP1 and CAGL0M09713g (Fig. 5) . Consistently, CgCDR1 and CgPUP1 genes were recently shown to be upregulated among a cohort of CgPdr1 GOF mutants different from those used to build (Fig. 5) (Ferrari et al. 2011) . The pattern of expression of other drug-efflux pumps varied according to the GOF mutation: while K274Q, L94S and P927L led to the upregulation of CgQDR2 and CgPHD1, K274N was the only mutation causing upregulation of CgTPO1-1 (Fig. 5) . The expression of adhesin-encoding genes was also found to vary according to the CgPdr1 GOF mutation (Fig 5) . This observation is particularly interesting in light of the described effect of CgPdr1 in contributing for C. glabrata adhesion to epithelial cells (Vale-Silva et al. 2013) . Surprisingly, the overlap between the genes regulated by the CgPdr1 GOF mutants K274N and K274Q was very limited (Fig. 5) demonstrating that even polymorphisms in the same CgPdr1 residue have a very different impact on the control of gene expression. One of the mechanisms that has been hypothesised to explain this divergence in the set of genes regulated by different CgPdr1 mutants is that they might be differently activated thereby resulting in a different interaction with the transcriptional machinery (Paul, Schmidt and Moye-Rowley 2011) . The different genetic background of the strains used in the different transcriptomic profilings may also contribute for some of the observed divergences.
In addition to contributing to maximal resistance to voriconazole and fluconazole, we also showed that the CgPDR1 K274Q allele is detrimental for growth of FFUL887 cells when cultivated in the presence of organic acids at a low pH. Similarly, cells expressing a CgPdr1 P927L GOF allele were also found to be susceptible to organic acids at a low pH (Vermitsky et al. 2006) . On the background of the KUE100 strain (derived from CBS138) which encodes a wild-type CgPdr1 allele, this phenotype towards organic acids was not observed indicating that it could be a feature of CgPdr1 GOF mutants, or at least of a subset of them. It is not possible with the data available until so far to clarify the reasons why the presence of organic acids seems to sensitise FFUL887 cells, although this is certainly a feature that deserves further exploration as it could be used to improve treatment of infections caused by isolates harbouring CgPdr1 GOF alleles. Besides contributing to better understand the acquisition of azole resistance, the comparative analyses of the genome and transcriptome of the CBS138 and FFUL887 strains also had the potential to elucidate some aspects underlying C. glabrata colonisation of the human urinary tract (the site where FFUL887 was retrieved from). In this sense, one of the observations that emerged from the comparative genomic analysis performed was the identification of several genes encoding adhesins as among those that had the higher number of non-synonymous SNPs in the FFUL887 strain. Adhesion is a fundamental step for C. glabrata ability to successfully colonise infection sites and as such adhesin-encoding genes are subjected to a tight selective pressure demonstrated to occur both at the transcriptional and genomic level (Halliwell et al. 2012; Carreté et al. 2017; Vale-Silva et al. 2017) . The microarray analysis performed revealed only two adhesin-encoding genes, CAGL0K10164g and CAGL0H08844g, as being upregulated in the FFUL887 strain; however, this analysis was performed using planktonic cells and thereby adhesion was not being favoured. The herein observed prominent differences in the primary sequence of the adhesins encoded by FFUL887 and CBS138, with emphasis for CgPwp4 which was the protein that differed the most in the two strains (Fig. 2) , shows that these genes are also subjected to a strong selective pressure probably to select those variants contributing more to improve adherence to the available surfaces. Another observation that emerged from the comparative transcriptomic analysis performed was the significant upregulation in the FFUL887 strain of genes involved in metabolism of amino acids and of sulphur as well as a large number of genes involved in metabolisation of fatty acids, glycogen and other carbon sources. Since the RPMI growth medium where the strains were cultivated for the transcriptomic analysis contains glucose (20 g/L) and sulphate (50 mg/L), the higher expression of these genes in the FFUL887 strain is more likely to reflect a higher basal level of expression compared to the one observed in the CBS138 strain. In C. glabrata, the presence of glucose in the medium does not appear to repress metabolisation of other carbon sources nor of the genes involved in those processes, as observed in S. cerevisiae (Bernardo et al. 2017; Cunha et al. 2017) . A similar alleviation of glucose repression over metabolism of alternative carbon sources was observed in C. albicans (Childers et al. 2016) . We have searched the genome sequence of the CBS138 and of the FFUL887 strains for genes homologous to those that mediate glucose repression in S. cerevisiae (Table S4 , Supporting Information). With the exception of the ScMTH1 gene, all the other genes mediating glucose repression in S. cerevisiae have robust homologues in CBS138 and in FFUL887; however, in some cases, there were marked differences between the S. cerevisae and the C. glabrata proteins, those more prominent being the Mig1, Mig2 and Mig3 transcriptional regulators (Table S4) . Further studies are required to understand the molecular players underlying the alleviation of glucose repression in C. glabrata and how their activity is modified by selective pressure during colonisation.
The increased resilience of C. glabrata to antifungal therapy and the persistent emergence of resistant strains is highly problematic considering the high rates of morbidity and mortality associated with infections caused by this pathogenic yeast. The results presented in this study provide a further contribution for a better understanding of the key players contributing for the acquisition of resistance in the host, with special emphasis on CgPdr1 transcription factor, a knowledge that can be used to guide the development of more efficient therapeutical strategies. Specifically, it was shown for the first time that the K274Q substitution results in a GOF CgPdr1 mutant and, consequently, in enhanced azole resistance. An observation of remark from our study and others was that the expression of the K274Q and of P927L CgPdr1 allele increases susceptibility to organic acids at a low pH, suggesting that these molecules could be used to sensitise azole-resistant strains dependent on CgPdr1 GOF alleles. The herein reported whole-genome analysis of the FFUL887 strain and subsequent comparison with CBS138 strain reinforced the extreme genetic diversity among C. glabrata strains providing clues into the adaptive responses evolved during colonisation of the human host and advancing current knowledge on the biology and physiology of this yeast species.
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